These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29792719)

  • 1. [Sinusoidal obstruction syndrome induced by monocrotaline in a large animal experiment - a pilot study].
    Pálek R; Liška V; Třeška V; Rosendorf J; Emingr M; Tégl V; Králíčková A; Bajcurová K; Jiřík M; Tonar Z
    Rozhl Chir; 2018; 97(5):214-221. PubMed ID: 29792719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Palek R; Rosendorf J; Maleckova A; Vistejnova L; Bajcurova K; Mirka H; Tegl V; Brzon O; Kumar A; Bednar L; Tonar Z; Hosek P; Moulisova V; Eberlova L; Treska V; Liska V
    Anticancer Res; 2020 Dec; 40(12):6817-6833. PubMed ID: 33288574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.
    Schiffer E; Frossard JL; Rubbia-Brandt L; Mentha G; Pastor CM
    J Surg Oncol; 2009 Jun; 99(7):439-46. PubMed ID: 19353590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
    Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
    J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinusoidal obstruction syndrome in the animal model: influence on liver surgery.
    Jafari A; Wehner S; Kalff JC; Manekeller S
    Langenbecks Arch Surg; 2017 Feb; 402(1):115-122. PubMed ID: 27585678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats.
    Conotte R; Colet JM
    Toxicol Appl Pharmacol; 2014 Apr; 276(2):147-56. PubMed ID: 24582690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extravasated platelet aggregation in the livers of rats with drug‑induced hepatic sinusoidal obstruction syndrome.
    Hirata M; Tajima H; Miyashita T; Miyata T; Nakanuma S; Makino I; Hayashi H; Oyama K; Takamura H; Ninomiya I; Fushida S; Nakata H; Iseki S; Harada S; Wakayama T; Ohta T
    Mol Med Rep; 2017 May; 15(5):3147-3152. PubMed ID: 28358421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
    Narita M; Hatano E; Ikai I; Miyagawa-Hayashino A; Yanagida A; Nagata H; Asechi H; Taura K; Uemoto S
    Ann Surg; 2009 May; 249(5):806-13. PubMed ID: 19387321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
    Miyata T; Tajima H; Hirata M; Nakanuma SI; Makino I; Hayashi H; Oyama K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Iseki S; Harada SI; Wakayama T; Ohta T
    J Gastroenterol Hepatol; 2018 Apr; 33(4):950-957. PubMed ID: 28960464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic oral sesame oil is ineffectual against monocrotaline-induced sinusoidal obstruction syndrome in rats.
    Periasamy S; Chien SP; Liu MY
    JPEN J Parenter Enteral Nutr; 2013 Jan; 37(1):129-33. PubMed ID: 22544841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    Stevenson HL; Prats MM; Sasatomi E
    BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
    Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
    Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
    van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
    Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
    Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
    Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic sesame oil attenuates sinusoidal obstruction syndrome by inhibiting matrix metalloproteinase-9 and oxidative stress.
    Periasamy S; Yang SS; Chen SY; Chang CC; Liu MY
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):529-37. PubMed ID: 22821006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome.
    DeLeve LD; Wang X; Kanel GC; Ito Y; Bethea NW; McCuskey MK; Tokes ZA; Tsai J; McCuskey RS
    Hepatology; 2003 Oct; 38(4):900-8. PubMed ID: 14512877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
    Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
    J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.